Molecular Mechanisms of AMH Signaling

Anti-Müllerian Hormone (AMH) is a secreted glycoprotein hormone with critical roles in reproductive development and regulation. Its chemical and mechanistic similarities to members of the Transforming Growth Factor β (TGF-β) family have led to its placement within this signaling family. As a member...

Full description

Bibliographic Details
Main Authors: James A. Howard, Kaitlin N. Hart, Thomas B. Thompson
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-06-01
Series:Frontiers in Endocrinology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fendo.2022.927824/full
_version_ 1811334716248293376
author James A. Howard
Kaitlin N. Hart
Thomas B. Thompson
author_facet James A. Howard
Kaitlin N. Hart
Thomas B. Thompson
author_sort James A. Howard
collection DOAJ
description Anti-Müllerian Hormone (AMH) is a secreted glycoprotein hormone with critical roles in reproductive development and regulation. Its chemical and mechanistic similarities to members of the Transforming Growth Factor β (TGF-β) family have led to its placement within this signaling family. As a member of the TGF-β family, AMH exists as a noncovalent complex of a large N-terminal prodomain and smaller C-terminal mature signaling domain. To produce a signal, the mature domain will bind to the extracellular domains of two type I and two type II receptors which results in an intracellular SMAD signal. Interestingly, as will be discussed in this review, AMH possesses several unique characteristics which set it apart from other ligands within the TGF-β family. In particular, AMH has a dedicated type II receptor, Anti-Müllerian Hormone Receptor Type II (AMHR2), making this interaction intriguing mechanistically as well as therapeutically. Further, the prodomain of AMH has remained largely uncharacterized, despite being the largest prodomain within the family. Recent advancements in the field have provided valuable insight into the molecular mechanisms of AMH signaling, however there are still many areas of AMH signaling not understood. Herein, we will discuss what is known about the biochemistry of AMH and AMHR2, focusing on recent advances in understanding the unique characteristics of AMH signaling and the molecular mechanisms of receptor engagement.
first_indexed 2024-04-13T17:12:15Z
format Article
id doaj.art-d53b9f300af34924b7c1388fdb7ecc3d
institution Directory Open Access Journal
issn 1664-2392
language English
last_indexed 2024-04-13T17:12:15Z
publishDate 2022-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Endocrinology
spelling doaj.art-d53b9f300af34924b7c1388fdb7ecc3d2022-12-22T02:38:14ZengFrontiers Media S.A.Frontiers in Endocrinology1664-23922022-06-011310.3389/fendo.2022.927824927824Molecular Mechanisms of AMH SignalingJames A. Howard0Kaitlin N. Hart1Thomas B. Thompson2Department of Pharmacology & Systems Physiology, University of Cincinnati, Cincinnati, OH, United StatesDepartment of Pharmacology & Systems Physiology, University of Cincinnati, Cincinnati, OH, United StatesDepartment of Molecular Genetics, Biochemistry, & Microbiology, University of Cincinnati, Cincinnati, OH, United StatesAnti-Müllerian Hormone (AMH) is a secreted glycoprotein hormone with critical roles in reproductive development and regulation. Its chemical and mechanistic similarities to members of the Transforming Growth Factor β (TGF-β) family have led to its placement within this signaling family. As a member of the TGF-β family, AMH exists as a noncovalent complex of a large N-terminal prodomain and smaller C-terminal mature signaling domain. To produce a signal, the mature domain will bind to the extracellular domains of two type I and two type II receptors which results in an intracellular SMAD signal. Interestingly, as will be discussed in this review, AMH possesses several unique characteristics which set it apart from other ligands within the TGF-β family. In particular, AMH has a dedicated type II receptor, Anti-Müllerian Hormone Receptor Type II (AMHR2), making this interaction intriguing mechanistically as well as therapeutically. Further, the prodomain of AMH has remained largely uncharacterized, despite being the largest prodomain within the family. Recent advancements in the field have provided valuable insight into the molecular mechanisms of AMH signaling, however there are still many areas of AMH signaling not understood. Herein, we will discuss what is known about the biochemistry of AMH and AMHR2, focusing on recent advances in understanding the unique characteristics of AMH signaling and the molecular mechanisms of receptor engagement.https://www.frontiersin.org/articles/10.3389/fendo.2022.927824/fullanti-müllerian hormone (AMH)anti-müllerian hormone receptor type II (AMHR2)transforming growth factor-β (TGF-β)bone morphogenetic protein (BMP)activinpersistent müllerian duct syndrome (PMDS)
spellingShingle James A. Howard
Kaitlin N. Hart
Thomas B. Thompson
Molecular Mechanisms of AMH Signaling
Frontiers in Endocrinology
anti-müllerian hormone (AMH)
anti-müllerian hormone receptor type II (AMHR2)
transforming growth factor-β (TGF-β)
bone morphogenetic protein (BMP)
activin
persistent müllerian duct syndrome (PMDS)
title Molecular Mechanisms of AMH Signaling
title_full Molecular Mechanisms of AMH Signaling
title_fullStr Molecular Mechanisms of AMH Signaling
title_full_unstemmed Molecular Mechanisms of AMH Signaling
title_short Molecular Mechanisms of AMH Signaling
title_sort molecular mechanisms of amh signaling
topic anti-müllerian hormone (AMH)
anti-müllerian hormone receptor type II (AMHR2)
transforming growth factor-β (TGF-β)
bone morphogenetic protein (BMP)
activin
persistent müllerian duct syndrome (PMDS)
url https://www.frontiersin.org/articles/10.3389/fendo.2022.927824/full
work_keys_str_mv AT jamesahoward molecularmechanismsofamhsignaling
AT kaitlinnhart molecularmechanismsofamhsignaling
AT thomasbthompson molecularmechanismsofamhsignaling